Simultaneous HPLC Determination of Oxcarbazepine, Carbamazepine and Their Metabolites in Serum
- 1 May 1984
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography
- Vol. 7 (6), 1235-1241
- https://doi.org/10.1080/01483918408074040
Abstract
We propose a simple procedure for the simultaneous determination of the anticonvulsants oxcarbazepine, carbamazepine and three of their metabolites (10-hydroxy-10, 11-dihydro-carbamazepine, trans-10, 11-dihydroxy-10, 11-dihydro-carbamazepine and 10, 11-epoxy-carbamazepine) in serum or plasma. The alkalinized sample is extracted with ethyl acetate. The extract is evaporated to dryness and taken up with the mobile phase. An aliquot is injected into the liquid chromatograph and eluted with water/methanol/acetonitrile (55/40/5, by vol.) on a 5-μm C-18 reversed-phase column. Eluent is monitored at 254 nm. No interference by other anticonvulsants or by endogenous constituents from the sample is observed. Owing to its good precision, specificity, sensitivity, and selectivity, this method is well adapted to the therapeutic monitoring of oxcarbazepine or carbamazepine treated patients, as well as for pharmacokinetic studies.This publication has 5 references indexed in Scilit:
- Determination of oxcarbazepine in human plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Quantitative determination of oxcarbazepineJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteersEuropean Journal of Clinical Pharmacology, 1982
- Pharmacokinetics of Carbamazepine in ManTherapeutic Drug Monitoring, 1979